Pristiq Extended-Release
NDC 0008-1210, desvenlafaxine succinate, tablet, extended release, from Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..
- Product NDC
- 0008-1210
- Status
- Listed
- Labeler
- Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021992
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0008-1210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DESVENLAFAXINE SUCCINATE25 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0008-1210-30 | 00008121030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1210-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0f43610c-f290-46ea-d186-4f998ed99fceNADAC price for package 00008121030
GET /v1/drugs/nadac/00008121030
Use it
Look up 0008-1210 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0008-1210 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0008-1210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.